Title:
NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2008/156142
Kind Code:
A1
Abstract:
It is intended to provide a novel compound which has AT2 receptor agonism
and is capable of being expected as a pharmaceutical and to provide a therapeutic
or preventive method for various diseases. A novel malonic acid sulfonamide
derivative, a pharmacologically acceptable salt thereof and a solvate thereof
of the invention has a therapeutic and/or preventive effect on various diseases
due to AT2 receptor agonism and is useful as a pharmaceutical for treating
and/or preventing diseases associated with the renin-angiotensin-aldosterone
(RAAS) system.
Inventors:
YOSHIDA TOMOHIRO (JP)
SAKASHITA HIROSHI (JP)
NUMATA ATSUSHI (JP)
TAHARA SAORI (JP)
KAWASUMI HISASHI (JP)
SAKASHITA HIROSHI (JP)
NUMATA ATSUSHI (JP)
TAHARA SAORI (JP)
KAWASUMI HISASHI (JP)
Application Number:
PCT/JP2008/061248
Publication Date:
December 24, 2008
Filing Date:
June 19, 2008
Export Citation:
Assignee:
MITSUBISHI TANABE PHARMA CORP (JP)
YOSHIDA TOMOHIRO (JP)
SAKASHITA HIROSHI (JP)
NUMATA ATSUSHI (JP)
TAHARA SAORI (JP)
KAWASUMI HISASHI (JP)
YOSHIDA TOMOHIRO (JP)
SAKASHITA HIROSHI (JP)
NUMATA ATSUSHI (JP)
TAHARA SAORI (JP)
KAWASUMI HISASHI (JP)
International Classes:
A61K31/18; C07C311/51; A61K31/192; A61K31/198; A61K31/223; A61K31/235; A61K31/27; A61K31/275; A61K31/341; A61K31/345; A61K31/351; A61K31/36; A61K31/381; A61K31/40; A61K31/4035; A61K31/404; A61K31/41; A61K31/415; A61K31/4155; A61K31/4164; A61K31/4166; A61K31/4184; A61K31/4192; A61K31/42; A61K31/421; A61K31/423; A61K31/426; A61K31/427; A61K31/438; A61K31/44; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/4439; A61K31/445; A61K31/4453; A61K31/4465; A61K31/4468; A61K31/454; A61K31/4545; A61K31/47; A61K31/4709; A61K31/472; A61K31/495; A61K31/496; A61K31/4965; A61K31/505; A61K31/517; A61K31/519; A61K31/5375; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/10; A61P9/12; A61P13/12; A61P25/00; A61P43/00; C07D209/08; C07D211/34; C07D211/58; C07D211/62; C07D211/96; C07D213/34; C07D213/56; C07D213/64; C07D213/74; C07D213/75; C07D213/81; C07D213/84; C07D215/18; C07D215/48; C07D217/06; C07D217/16; C07D221/20; C07D231/12; C07D231/14; C07D233/60; C07D233/61; C07D233/72; C07D235/16; C07D235/18; C07D239/28; C07D249/04; C07D257/04; C07D261/18; C07D263/32; C07D263/34; C07D263/58; C07D277/20; C07D277/26; C07D277/30; C07D277/82; C07D295/14; C07D295/16; C07D295/22; C07D307/68; C07D307/70; C07D309/14
Foreign References:
| JPS4885594A | 1973-11-13 | |||
| GB1339708A | 1973-12-05 | |||
| US3763154A | 1973-10-02 | |||
| JP2004533457A | 2004-11-04 |
Other References:
JOURNAL OF MEDICINAL CHEMISTRY, vol. 49, no. 24, 2006, pages 7160 - 7168, XP008126707
ISHIZUKA ET AL., SYNTHESIS, 2000, pages 784 - 788
JANSEN ET AL., EUR. J. MED. CHEM., vol. 38, 2003, pages 855 - 865
CHAKRAVARTY ET AL., BIOORG. MED. CHEM. LETT., vol. 4, 1994, pages 75 - 80
SAKAKI ET AL., BIOORG. MED. CHEM. LETT., vol. 8, 1998, pages 2241 - 2246
DONKOR ET AL., EUR. J. MED. CHEM., vol. 33, 1998, pages 15 - 22
See also references of EP 2172450A4
ISHIZUKA ET AL., SYNTHESIS, 2000, pages 784 - 788
JANSEN ET AL., EUR. J. MED. CHEM., vol. 38, 2003, pages 855 - 865
CHAKRAVARTY ET AL., BIOORG. MED. CHEM. LETT., vol. 4, 1994, pages 75 - 80
SAKAKI ET AL., BIOORG. MED. CHEM. LETT., vol. 8, 1998, pages 2241 - 2246
DONKOR ET AL., EUR. J. MED. CHEM., vol. 33, 1998, pages 15 - 22
See also references of EP 2172450A4
Attorney, Agent or Firm:
TAKASHIMA, Hajime (Midosuji Bldg. 1-1,Fushimimachi 4-chome,Chuo-ku, Osaka-shi, Osaka 44, JP)
Download PDF: